INGENUITY PATHWAY ANALYSIS SOFTWARE

Acquisition of one concurrent user license for Ingenuity Pathway Analysis Software or equal. Requirements The Ingenuity Pathway Analysis Match CL license or equal shall contain the following salient characteristics: • Shall be web based Shall be compatible with the Ingenuity Knowledge Base and Ingenuity Ontology software Shall be compatible with the existing research workflow and third-party analysis software NCTR is using, including, but not limited to, ArrayTrack, SAS JMP and R/Bioconductor. Shall be compatible with ArrayTrack, SAS JMP and R/Bioconductor Shall be capable of supporting gene identifiers from, but not limited to, Affymetrix, Agilent, Applied Biosystems, CAS registry, Entrez, Ensembl, GenBank, GenPept, HUGO, the Human Metabolome Database, Illumina, the International Protein Index, KEGG, PubChem, RefSeq, SwissProt, UniGene and Uniprot Shall provide causal network analysis and appropriate analysis of data derived from gene expression, microRNA and next generation sequencing (NGS) Shall be concurrent and not tied to named users or computer Shall be on the FDA Master Approved Technology list Shall comply with Section 508 of the Rehabilitation Act (the Act) of 1973 M aintenance and Technical Support: In order for a Quoter’s offer to be deemed technically acceptable, the Vendor shall: • Provide fixes, security alerts and critical patch updates. • Licenses shall include maintenance, support, and any upgrades necessary to maintain the system. P e r iod of Performance/Delivery The period of performance shall be base year and 4 option year as listed below Instructions to Quoters Quoters shall submit a complete pricing for all products listed in this RFQ and overall cost to the Government. Partial quotes will not be considered. Incomplete pricing or pricing with omissions may not be considered for award. Quoters should ensure that their initial submission represents their best pricing and that all information is provided to determine technical acceptability. The Government will not research items to determine compatibility; all information regarding compatibility must be contained within the quotation. Quotations shall meet all the requirements of this solicitation in order to be considered technically acceptable. Quoters shall submit all assumptions in their quotation. Quoter shall be an Original Equipment Manufacturer, authorized reseller and/or servicing agent of the software manufacturer. Quotes shall meet all the salient characteristics of this solicitation. Quotes should contain all requirements outlined in Section 3 of this solicitation. Quoters shall submit all applicable terms and conditions in full text as attachments, appendix, or exhibits. Equal to Quotes must submit Technical volume with detailed point-by-point description of how the equal to product meets all the salient characteristics of this solicitation in Section 4 of this solicitation. Quoters submitting equal to products, shall submit Section 508 Product Accessibility Templates (PAT) in full text with their quotations. For more information regarding PATs see: http://www.hhs.gov/web/section-508/contracting/technology-products/product-accessiblity-template/ Questions and quotes shall be submitted electronically via email to Sephora Calderon at [email protected]. Evaluation: All quotes will be evaluated on a Lowest Priced Technically Acceptable (LPTA) basis. All quotes will be evaluated on proposed products that meet or exceed all the salient characteristics specified in Section 3 of this solicitation. The Government will evaluate the quotation that it meets the requirement in section 3 and Section 4 of the solicitation to include description, quantity, period of performance and pricing for the deliverables Section 508 Product Accessibility Basis for Award All quotations will be evaluated on a Lowest Priced Technically Acceptable (LPTA) basis. The award will be made to the lowest price Quoter that demonstrates they can meet all the requirements of this solicitation. Failure to demonstrate meeting any of the requirements will result in a rating of technically unacceptable and will not be considered for award.